中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (11): 1000-1007.doi: 10.35541/cjd.20230247

• 指南与共识 • 上一篇    下一篇

中国中重度特应性皮炎诊疗临床路径专家共识(2023版)

中华医学会皮肤性病学分会    中国医师协会皮肤科医师分会   

  1. 中华医学会皮肤性病学分会    中国医师协会皮肤科医师分会
  • 收稿日期:2023-04-28 修回日期:2023-06-30 发布日期:2023-11-03
  • 通讯作者: 宋志强;高兴华 E-mail:drsongzq@hotmail.com; gaobarry@ hotmail.com

Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus

Chinese Society of Dermatology, China Dermatologist Association   

  1. Chinese Society of Dermatology, China Dermatologist Association
  • Received:2023-04-28 Revised:2023-06-30 Published:2023-11-03
  • Contact: Song Zhiqiang; Gao Xinghua E-mail:drsongzq@hotmail.com; gaobarry@ hotmail.com

摘要: 【摘要】 为促进我国中重度特应性皮炎诊断及治疗的规范化和标准化,中华医学会皮肤性病学分会、中国医师协会皮肤科医师分会组织国内皮肤科特应性皮炎专家通过联合应用文献分析、专题讨论和专家咨询,组织撰写中国中重度特应性皮炎诊疗临床路径。本临床路径首先介绍特应性皮炎的诊断依据,评估、筛查及检查项目和进入路径标准;其次详细描述中重特应性皮炎的治疗原则、方案和药物,疗效判断、随访与评估指标,患者教育及指导,完成路径标准和变异及原因分析;建议诱导缓解治疗的疗程不应低于3个月,诱导治疗获得缓解后至少应制定3 ~ 6个月的维持缓解治疗目标;最后以附录的形式列出中重度特应性皮炎诊疗管理流程和中重度特应性皮炎诊疗临床路径表单。

关键词: 皮炎, 特应性, 诊断, 治疗, 缓解诱导, 临床路径

Abstract: 【Abstract】 In order to promote the standardization of diagnosis and treatment of moderate to severe atopic dermatitis in China, Chinese Society of Dermatology and China Dermatologist Association organized Chinese experts to establish a clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis, through a combined approach of literature analysis, thematic discussion, and expert consultation. Firstly, the diagnosis, assessment, screening, and examination items for atopic dermatitis, as well as entry criteria for clinical pathway were described; secondly, the treatment principles, regimens and drugs for moderate to severe atopic dermatitis were elaborated, so were the efficacy assessment, follow-up and evaluation indicators, patient education and guidance, standards for pathway completion, pathway variation and its cause analysis; it was suggested that the course of induction treatment should not be less than 3 months, and the plan of maintenance treatment should be set for at least 3 - 6 months after the efficacy of induction treatment was achieved; finally, the management process and the clinical pathway form for the diagnosis and treatment of moderate to severe atopic dermatitis were listed in the appendixes.

Key words: Dermatitis, atopic, Diagnosis, Therapy, Remission induction, Clinical pathway

引用本文

中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会. 中国中重度特应性皮炎诊疗临床路径专家共识(2023版)[J]. 中华皮肤科杂志, 2023,56(11):1000-1007. doi:10.35541/cjd.20230247

Chinese Society of Dermatology, China Dermatologist Association. Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus[J]. Chinese Journal of Dermatology, 2023, 56(11): 1000-1007.doi:10.35541/cjd.20230247